ALPELISIB PLUS FULVESTRANT FOR PIK3CA-MUTATED, HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH RECEPTOR-2-NEGATIVE ADVANCED BREAST CANCER

Additional Metadata
Keywords	Cost-effectiveness analysis;Alpelisb;Advanced Breast cancer
Thesis Advisor	Wetzelaer, P.
Persistent URL	hdl.handle.net/2105/62490
Series	Master Health Economics, Policy and Law
Organisation	Erasmus School of Health Policy & Management
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Walraven, M.M.H. (2021, August 12). ALPELISIB PLUS FULVESTRANT FOR PIK3CA-MUTATED, HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH RECEPTOR-2-NEGATIVE ADVANCED BREAST CANCER. Master Health Economics, Policy and Law. Retrieved from http://hdl.handle.net/2105/62490

Publication